Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B
Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B
Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B
Submitted by
admin
on November 5, 2011 - 2:46pm
Source:
Yahoo/BusinessWire
News Tags:
Viread
Gilead Sciences
hepatitis B
Headline:
Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B
Do Not Allow Advertisers to Use My Personal information